Biography:
During his studies in organic chemistry at university of Nice Sophia-Antipolis, Kevin worked as trainee on the synthesis of a molecular probe of a promising anticancer quinuclidinone derivative to the elucidation of its biological mode of action. After graduating from master “Fragrance & Fine Chemistry” at Côte-d’Azur University in 2020, He started a PhD on “Molécules Bioactives” team to develop new chimeric molecules able to degrade known oncogenic proteins to circumvent resistance mechanisms in leukemias. He is also working on the synthesis of new non-planar heterocycles with high medicinal potential.
